C50.022
BillableMalignant neoplasm of nipple and areola, left male breast
HCC Category Mapping
What This Code Means
Breast cancer that starts in the nipple or the dark area around the nipple (areola) on the left breast in a male patient.
Coding Tips
- •The first '0' indicates nipple and areola location; the '2' specifies left breast; the final '2' indicates male
- •Confirm both gender and laterality are documented, as male breast cancer with specific site location is uncommon
Clinical Significance
Malignant neoplasm of the nipple and areola, left male breast represents invasive breast cancer requiring staging, treatment planning, and ongoing surveillance. Breast cancer is risk-adjusted because it demands significant healthcare resources including surgery, radiation, chemotherapy, hormonal therapy, and long-term monitoring. Male breast cancer accounts for less than 1% of all breast cancers, making accurate gender-specific coding particularly important for tracking and research.
Documentation Requirements
- ✓Pathologic confirmation of malignancy — distinguish Paget disease of nipple from invasive carcinoma with nipple involvement
- ✓Laterality: left breast
- ✓Gender documented as male to support gender-specific code selection
- ✓Quadrant or subsite location: nipple and areola
- ✓Tumor size (T stage) and grade
- ✓Lymph node status (N stage) — axillary, sentinel node biopsy results
- ✓Estrogen receptor, progesterone receptor, and HER2 status
- ✓Stage grouping (I-IV)
- ✓Current treatment status (active treatment, hormonal therapy, surveillance)